Kristen K. Buck - Jan 10, 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role: EVP, R&D and CMO
Signature: Kristen K. Buck, by Todd Girolamo, Esq., Attorney-in-Fact
Stock symbol: LSTA
Transactions as of: Jan 10, 2022
Transactions value $: -$7,055
Form type: 4
Date filed: 1/12/2022, 03:18 PM
Previous filing: Sep 3, 2021
Next filing: Sep 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+64.5K	+24.58%	$0.00	327K	Jan 10, 2022	Direct	F1, F2
transaction	LSTA	Common Stock	Tax liability	-$7.06K	-7.69K	-2.35%	$0.92	319K	Jan 10, 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Option (Right to Buy)	Award	$0	+32.5K		$0.00	32.5K	Jan 10, 2022	Common Stock	32.5K	$0.92	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 64,500 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2	Includes 257,750 unvested restricted stock.
F3	Shares withheld as payment of a tax liability on vesting of restricted stock.
F4	One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.